HealthcareHealthcare ServicesHospital

GPT Healthcare Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 51 filings·Updated 28 Sept 2026
Showing 10 of 51 filings.
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

GPT Healthcare Limited — Closure of Trading Window from October 01, 2026 until 48 hours after the declaration of Un-Audited Financial Results for the 2nd quarter and half year ending September 30, 2026.

GPT Healthcare Limited — Closure of Trading Window from October 01, 2026 until 48 hours after the declaration of Un-Audited Financial Results for the 2nd quarter and half year ending September 30, 2026.

Filed 10:18View Source
21 Sept 20261 filing
Company UpdateAnalyst / Investor Meet

GPT Healthcare to host virtual investor meeting with analysts on Sept 28, 2026 at 11:00 IST

Meeting Details

  • Date and time: September 28, 2026, 11:00 AM IST.
  • Type and mode: Group meeting, virtual.
  • Event/organiser: Bharat Connect – Arihant Capital Virtual Conference.

Participants

  • Key company participants: Company Secretary and Compliance Officer.

Purpose

  • Purpose: Group investor/analyst interaction under SEBI LODR.
  • Discussion will be based on publicly available information.

Additional Notes

  • Investor presentation (Q1FY27) will be used and is publicly available on company and stock exchange sites.
Filed 15:52View Source
7 Aug 20262 filings
Company UpdateEarnings Call Transcript

GPT Healthcare Q1 FY27: Revenue up 18.2% YoY; PAT up 66%; occupancy improving across mature hospitals; expansion on track.

Financial Performance

  • Q1 FY27 revenue: INR126.2 crores; EBITDA: INR26.2 crores; EBITDA margin: 20.4%.
  • PAT for the quarter: INR12.7 crores; PAT margin: 9.9%.
  • Total income rose 18.2% YoY; PAT rose 66% YoY.
  • Overall occupancy 45.5%; ARPOB INR42,350.
  • Excluding Raipur, mature-hospital occupancy 58.07%.

Operational Highlights

  • Salt Lake occupancy 62%; ARPOB INR45,300; robotic procedures >800.
  • Dumdum: occupancy 65%; ARPOB INR43,041; renal transplants >700.
  • Agartala: July occupancy 51%; ARPOB INR41,573; cancer center with PET/Linear Accelerator; 700+ radiations.
  • Howrah: revenue up 31% YoY; occupancy up 16%.
  • Raipur: occupancy 17%; liver transplant performed; on track to breakeven.
  • Jamshedpur: 155-bed hospital to be commissioned in Q4 FY27.
  • 7th hospital shortlist: Cuttack, Ranchi, Patna, Banaras, Prayagraj.
  • Asset-light model: Raipur and Jamshedpur rent-based; reduces real estate investment.
  • Rentals for Raipur and Jamshedpur around mid-30s INR.
  • Jamshedpur debt around INR25 crores to be raised in FY27.
  • Exit Raipur occupancy target around 30% by year-end.
  • Raipur breakeven expected in about 20 months.
  • Jamshedpur breakeven expected in about 24 months.
  • Tariff increase generally in October; current quarter had no tariff hike.
  • Bangladesh inbound: visa policy linked to targeted hospitals; expect pre-disruption levels in 6 months.
  • Attrition: doctors in Calcutta single digits; Agartala/Raipur around 10%.

Outlook and Capital Allocation

  • Long-term ROE/ROCE target around 25%.
  • Seventh hospital planned to lift network to over 1,000 beds in 2 years.

Q&A Highlights

  • Raipur exit occupancy target by year-end ~30%.
  • Jamshedpur breakeven ~24 months.
  • Tariff hikes: October; no current quarter increase.
  • Bangladesh inflows improving; visas tied to targeted hospitals; recovery in 6 months.
  • Attrition: doctors Calcutta low single digits; Agartala/Raipur ~10%.
  • Eastern India focus on Tier 1–2 cities for future expansion.
Filed 19:44View Source
AGM/EGMAGM

GPT Healthcare Ltd AGM 2026 approves dividend, cost audit remuneration, and reappoints independent directors via VC/OAVM

AGM details

  • Date and time: 6 Aug 2026, 3:00 PM.
  • Mode: VC/OAVM.
  • Record date: 30 Jul 2026.
  • End time: 4:22 PM.

Resolutions and outcomes

  • Resolution 1 (Ordinary): Adopt audited financial statements with Board and Auditors; passed.
  • Resolution 2 (Ordinary): Interim dividend paid; final dividend proposed; passed.
  • Resolution 3 (Ordinary): Director re-appointment by rotation; passed.
  • Resolution 4 (Ordinary): Ratify remuneration of Cost Auditors; passed.
  • Resolution 5 (Ordinary): Increase in remuneration of Vice President; passed.
  • Resolution 6 (Ordinary): Approve professional fees to consultant relative; passed.
  • Resolution 7 (Special): Re-appoint Independent Director; passed.
  • Resolution 8 (Special): Re-appoint Independent Director; passed.
  • Resolution 9 (Special): Continue Independent Director beyond age 75; passed.
  • Resolution 10 (Special): Approve Doctor consultancy fees to Non-Executive Director; passed.

Directors and governance changes

  • Rotation-based re-appointment approved for one director.
  • Two independent directors reappointed for a second five-year term.
  • Continuation of a non-executive independent director beyond age 75.

Auditors

  • Cost Auditor remuneration ratified for the upcoming year; approved basis and expenses.
  • Authority given to executives to file necessary forms.

Material related party transactions

  • Remuneration increases to relative of directors approved.
  • Consultancy payments to relatives of directors approved.
  • Fees for director-related doctor consultancy approved.
Filed 17:15View Source
6 Aug 20261 filing
AGM/EGMAGM

GPT Healthcare's 37th AGM held via VC/OAVM on August 6, 2026; dividend approved and director reappointments

AGM Details

  • AGM held on August 6, 2026 at 3:00 PM IST via VC/OAVM.
  • Record (Cut-off) date for voting: July 30, 2026.
  • Meeting duration: 3:00 PM to 4:26 PM IST, including e-voting.

Key Resolutions

  • Ordinary: Adopt audited financial statements and Reports of Directors and Auditors.
  • Ordinary: Approve interim dividend and declare final dividend for FY 2025-26.
  • Ordinary: Re-appoint Dr. Aruna Tantia, who retires by rotation.
  • Special: Ratify Cost Auditor remuneration for FY 2026-27.
  • Special: Approve increased remuneration for Dr. Mridul Tantia, Vice President.
  • Special: Approve payment of professional fees to Dr. Niharika Tantia.
  • Special: Re-appoint Hari Modi as Independent Director.
  • Special: Re-appoint Dr. Tapti Sen as Independent Director.
  • Special: Continue Amrendra Verma as Non-Executive Independent Director beyond age 75.
  • Special: Approve Doctor Consultancy Fees to Dr. Ghanshyam Goyal.

Director Changes

  • Aruna Tantia retires by rotation; eligible for re-appointment.
  • Hari Modi re-appointed as Independent Director.
  • Tapti Sen re-appointed as Independent Director.
  • Amrendra Verma to continue as Non-Executive Independent Director beyond 75.
Filed 20:31View Source
4 Aug 20261 filing
Company UpdateAnalyst / Investor Meet

GPT Healthcare holds investor conference call on Q1 FY2026 unaudited results; audio recording available

Meeting Details

  • Date and time: August 4, 2026, 11:00 AM IST.
  • Type and mode: group virtual conference call with investors.
  • Event: investor conference call.

Participants

  • Key company participants: company management present; roles not specified.

Purpose

  • Purpose: discuss Un-Audited Q1 FY2026 results for quarter ended June 30, 2026.

Additional Notes

  • Recording: Audio recording available; uploaded on company website.
Filed 14:09View Source
3 Aug 20263 filings
Company UpdatePress Release / Media Release

GPT Healthcare reports Q1FY27 unaudited total income Rs 128.2 crore; growth and expansion updates

Key highlights

  • Q1FY27 total income Rs 128.2 crore, up 18% YoY.
  • EBITDA Rs 26.2 crore; margin 20.4%.
  • PAT Rs 12.7 crore; margin 9.9%.
  • FY26 total income Rs 478.5 crore; EBITDA Rs 90.1 crore; PAT Rs 42.2 crore.
  • ARPOB at Rs 42,350; occupancy 58.07% excluding Raipur.
  • Overall occupancy including Raipur 45.5%.
  • Dum Dum: over 700 renal transplants.
  • Howrah: MAKO robotic knee surgery launched.
  • Agartala: over 700 RT procedures.
  • Salt Lake: over 800 robotic surgeries.
  • Raipur: liver transplant license; break-even by Q3 FY27.
  • Jamshedpur: completion on track for Q4 FY27.
  • BEMAKI AKI trial participation strengthens clinical footprint.
Filed 17:25View Source
Company UpdateInvestor Presentation

GPT Healthcare Q1 FY27: Revenue Rs 128.2 Cr; EBITDA Rs 26.2 Cr; PAT Rs 12.7 Cr

Operational highlights

  • ARPOB at ₹39,243 per day amid improved mix and efficiency.
  • Network occupancy 45.5% (Raipur excluded 58.07%).
  • Salt Lake: 800+ cumulative robot-assisted surgeries.
  • Dum Dum: renal transplant program with 700+ transplants.
  • Agartala launched PET scan and LINAC; 700+ radiation procedures.
  • Howrah launched MAKO knee replacement surgeries.
  • Raipur high-acuity ramp-up; on track to breakeven by Q3 FY27.
  • Strategy targets 70% occupancy and 1,000 beds in two years.
  • Long-term ROCE targeted at ~25% from efficient asset use.

Strategic expansion & outlook

  • Jamshedpur 155-bed facility MoU; commissioning targeted by end-FY27.
  • Planned Tier II entry in UP, Assam, Odisha with fixed rentals.
  • Expansion to reach 1,000 beds; ROCE ~25%.

Financial performance

  • Total revenue Rs 128.2 Cr; YoY growth 18%.
  • EBITDA Rs 26.2 Cr; EBITDA margin 20.4%.
  • PAT Rs 12.7 Cr; PAT margin 9.9%.

Governance & leadership

  • Dr. Om Tantia: Chairman & MD; leading ILS Hospitals.
  • Board includes independent directors; emphasis on governance.
Filed 17:21View Source
ResultFinancial Results

GPT Healthcare reports unaudited Q1 FY27 results; revenue ₹12,620.43 lakhs, PAT ₹1,273.14 lakhs.

Quarterly results snapshot

  • Revenue from operations: ₹12,620.43 lakhs; total income: ₹12,823.04 lakhs.
  • Profit after tax: ₹1,273.14 lakhs; EPS: ₹1.55 (basic/diluted).
  • Total comprehensive income: ₹1,271.88 lakhs; OCI net: ₹-1.26 lakhs.
  • Total expenses: ₹11,106.57 lakhs; major costs: materials ₹2,414.86; employee benefits ₹2,323.69.
  • PBT: ₹1,716.47 lakhs; tax: ₹443.33 lakhs.
  • Single reportable segment: healthcare services in India.
  • No subsidiary/associate; standalone results only.
  • Auditors' review: unmodified conclusion.
  • Paid-up equity capital: ₹8,205.48 lakhs.
Filed 16:46View Source
25 Jul 20261 filing
Company UpdateAnalyst / Investor Meet

GPT Healthcare schedules August 4, 2026 earnings call to discuss Q1 FY27 results

Meeting Details

  • Date and time: August 4, 2026 at 11:00 IST
  • Meeting type and mode: conference call, group, virtual
  • Organizer: GPT Healthcare Limited

Participants

  • Key company participants: Group CFO, Executive Director, CFO

Purpose

  • Discuss Un-Audited Q1 FY27 results for quarter ended June 30, 2026
Filed 14:08View Source
Showing 10 of 51 filings